CorMedix Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-30

Reporting Person: LENZ BRIAN (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock, $0.001 par value per share	P	2000	—	Acquired	2000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	Stock option (right to buy)	$3.1250	A	326492	Acquired	2020-03-30	Common Stock, $0.001 par value per share (326492)	Direct
2010-03-30	Warrants issued as a part of Units	$3.4375	P	1000	Acquired	2015-03-24	Common Stock, $0.001 par value per share (1000)	Direct

Footnotes

F1: These securities were issued as a part of 1,000 Units purchased by Mr. Lenz directly from the underwriters in the Company's initial public offering, which closed on
March 30, 2010. The Units were purchased at $6.50 per Unit, the initial public offering price. Each Unit consists of two shares of common stock and a warrant to
purchase one share of common stock.

F2: These options vest as follows: 1/3 on March 30, 2011; an additional 1/3 on March 30, 2012; and the remaining 1/3 on March 30, 2013.

F3: These warrants will become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment option with respect to the Company's initial
public offering, or the exercise in full of such over allotment option.